4Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$823K Sell
669
-2
-0.3% -$2.04K 0.63% 50
2026
Q1
$595K Buy
671
+2
+0.3% +$2.03K 0.51% 67
2025
Q4
$719K Sell
669
-10
-1% -$9.56K 0.61% 53
2025
Q3
$518K Buy
679
+25
+4% +$18.6K 0.46% 73
2025
Q2
$510K Buy
654
+5
+0.8% +$3.88K 0.52% 66
2025
Q1
$536K Sell
649
-49
-7% -$40.8K 0.58% 60
2024
Q4
$539K Buy
+698
New +$578K 0.54% 58

Other funds holding LLY

4Wealth Advisors's LLY Position: Q2 2026 in Review

4Wealth Advisors reduced its Eli Lilly (LLY) stake by 0.3% in Q2 2026, selling an estimated $2.04K and leaving 669 shares worth $823K. The position accounts for 0.63% of the portfolio, ranked #50.

4Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,720 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 4Wealth Advisors held 669 shares of Eli Lilly worth $823K as of Q2 2026.
  • 4Wealth Advisors sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.63% of 4Wealth Advisors's portfolio in Q2 2026, its #50 holding.
  • 4Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,720 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 4Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.